Efficacy evaluation of Chinese herbal medicine, VGH-BPH1, for patients with benign prostatic hyperplasia: A randomized, double-blind, placebo-controlled, and crossover study-Reference-Cited by-同舟云学术

Efficacy evaluation of Chinese herbal medicine, VGH-BPH1, for patients with benign prostatic hyperplasia: A randomized, double-blind, placebo-controlled, and crossover study

Published:2022-05 Issue:5 Volume:85 Page:639-646
ISSN:1726-4901
Container-title:Journal of the Chinese Medical Association
language:en
Short-container-title:

Author:

Tran Diem Ngoc Hong,Yeh Hsin-Fu,Huang William J.,Wu Pei-Wen,Liao Ying-Ju,Hwang Shinn-Jang,Kung Yen-Ying,Yang Jen-Lin,Wu Ta-Peng,Hsu Chung-Hua,Chen Fang-Pey

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference36 articles.

1. The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis.;Nickel;Curr Opin Urol,2006

2. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.;Abrams;Urology,2003

4. Benign prostatic hyperplasia: a clinical review.;Skinder;JAAPA,2016

5. The effect of alpha-blocker and 5alpha-reductase inhibitor intake on sexual health in men with lower urinary tract symptoms.;Barqawi;BJU Int,2007

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network pharmacology and experimental validation to explore the pharmacological mechanism of saw palmetto and its core ingredients in benign prostatic hyperplasia treatment;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-17

2. The 2022 Journal of Chinese Medical Association Award-Winning Research illuminates the promise of integrating acupuncture and related techniques in rheumatoid arthritis treatment;Journal of the Chinese Medical Association;2023-07-18